Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Ceapro Inc > wound dressings - next stage?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2015)
•••
Comment by Ciaoon Nov 07, 2022 1:58pm
95 Views
Post# 35079514

RE:wound dressings - next stage?

RE:wound dressings - next stage?The TAM for wound dressing is expected to have a CAGR of 9.7% so that the global market would be over $11B USD by 2025.

https://www.marketsandmarkets.com/Market-Reports/wound-dressings-market-123903496.html?gclid=CjwKCAiA9qKbBhAzEiwAS4yeDWkzM25V8zGIIx2eL64LQc8uvdmyhPcjMYcotqfw5nylCxpsSRRd0xoCVjgQAvD_BwE

I would be interested to see quickly we could get a partner as this would be a lucrative market for them. A partner could do the clinical studies whereas Ceapro would supply the loaded substrates based on the customer's design for bioactives.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities